SDSonya Dave

Sonya Dave

*This is an algorithmically generated author record based on publicly available information.

Sonya Dave has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Vitamin C improves gut Bifidobacteria in humans

    by Sabine Hazan, Sonya Dave, Andreas J Papoutsis, Nirupama Deshpande, Mark C Howell, Leisha Ma Martin

    Aims: Numerous beneficial effects of vitamin C (ascorbic acid) supplementation have been reported in the literature. However, data on its effects toward the gut microbiome are limited. We assessed ... Plain language summary Vitamin C, also known as ascorbic acid, is used as a supplement for fighting infectious disorders. Many disorders, including COVID-19 and cancer, harmfully disrupt the levels... Tweetable abstract Patients receiving ascorbic acid supplementation had increased abundance of Bifidobacterium in their gut microbiome, which may help to explain some of the apparent health benefit...


  • Letter in Reply: More Power To Ivermectin Multidrug Therapy

    by Sabine Hazan, Sonya Dave, Thomas J Borody, Peter A McCullough

  • Open Access

    Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity

    by Sabine Hazan, Neil Stollman, Huseyin S Bozkurt, Sonya Dave, Andreas J Papoutsis, Jordan Daniels, Brad D Barrows, Eamonn Mm Quigley, Thomas J Borody

    Objective: The study objective was to compare gut microbiome diversity and composition in SARS-CoV-2 PCR-positive patients whose symptoms ranged from asymptomatic to severe versus PCR-negative exposed controls. Design: Using a cross-sectional design, we performed shotgun next-generation sequencing on stool samples to evaluate gut microbiome composition and diversity in both patients with SARS-CoV-2 PCR-confirmed infections, which had presented to Ventura Clinical Trials for care from March 2020 through October 2021 and SARS-CoV-2 PCR-negative exposed controls. Patients were classified as being asymptomatic or having mild, moderate or severe symptoms based on National Institute of Health criteria. Exposed controls were individuals with prolonged or repeated close contact with patients with SARS-CoV-2 infection or their samples, for example, household members of patients or frontline healthcare workers. Microbiome diversity and composition were compared between patients and exposed controls at all taxonomic levels. Results: Compared with controls (n=20), severely symptomatic SARS-CoV-2-infected patients (n=28) had significantly less bacterial diversity (Shannon Index, p=0.0499; Simpson Index, p=0.0581), and positive patients overall had lower relative abundances of Bifidobacterium (pFaecalibacterium (p=0.0077) and Roseburium (p=0.0327), while having increased Bacteroides (p=0.0075). Interestingly, there was an inverse association between disease severity and abundance of the same bacteria. Conclusion: We hypothesise that low bacterial diversity and depletion of Bifidobacterium genera either before or after infection led to reduced proimmune function, thereby allowing SARS-CoV-2 infection to become symptomatic. This particular dysbiosis pattern may be a susceptibility marker for symptomatic severity from SARS-CoV-2 infection and may be amenable to preinfection, intrainfection or postinfection intervention. Trial registration number: NCT04031469 (PCR−) and 04359836 (PCR+).


  • Retracted
    Open Access

    RETRACTED ARTICLE: Effectiveness of Ivermectin-Based Multidrug Therapy in Severely Hypoxic, Ambulatory COVID-19 Patients

    by Sabine Hazan, Sonya Dave, Anoja W Gunaratne, Sibasish Dolai, Robert L Clancy, Peter A McCullough, Thomas J Borody

    Aims: Ivermectin is a safe, inexpensive and effective early COVID-19 treatment validated in 20+ random, controlled trials. Having developed combination therapies for Helicobacter pylori, the author...


  • Open Access

    Methamphetamine decreases K + channel function in human fetal astrocytes by activating the trace amine‐associated receptor type‐1

    by Sonya Dave, Lihua Chen, Chunjiang Yu, Melanie Seaton, Christina E. Khodr, Lena Al‐Harthi, Xiu‐Ti Hu

    Methamphetamine (Meth) is a potent and commonly abused psychostimulant. Meth alters neuron and astrocyte activity; yet the underlying mechanism(s) is not fully understood. Here we assessed the impact of acute Meth on human fetal astrocytes (HFAs) using whole‐cell patch‐clamping. We found that HFAs displayed a large voltage‐gated K + efflux ( I Kv ) through K v /K v ‐like channels during membrane depolarization, and a smaller K + influx ( I kir ) via inward‐rectifying K ir /K ir ‐like channels during membrane hyperpolarization. Meth at a ‘recreational’ (20 μM) or toxic/fatal (100 μM) concentration depolarized resting membrane potential (RMP) and suppressed I Kv/Kv‐like . These changes were associated with a decreased time constant ( Ƭ ), and mimicked by blocking the two‐pore domain K + (K 2P )/K 2P ‐like and K v /K v ‐like channels, respectively. Meth also diminished I Kir/Kir‐like , but only at toxic/fatal levels. Given that Meth is a potent agonist for the trace amine‐associated receptor type‐1 (TAAR1), and TAAR1‐coupled cAMP/cAMP‐activated protein kinase (PKA) cascade, we further evaluated whether the Meth impact on K + efflux was mediated by this pathway. We found that antagonizing TAAR1 with N ‐(3‐Ethoxyphenyl)‐4‐(1‐pyrrolidinyl)‐3‐(trifluoromethyl)benzamide (EPPTB) reversed Meth‐induced suppression of I Kv/Kv‐like ; and inhibiting PKA activity by H89 abolished Meth effects on suppressing I Kv/Kv‐like . Antagonizing TAAR1 might also attenuate Meth‐induced RMP depolarization. Voltage‐gated Ca 2+ currents were not detected in HFAs. These novel findings demonstrate that Meth suppresses I Kv/Kv‐like by facilitating the TAAR1/G s /cAMP/PKA cascade and altering the kinetics of K v /K v ‐like channel gating, but reduces K 2P /K 2P ‐like channel activity through other pathway(s), in HFAs. Given that Meth‐induced decrease in astrocytic K + efflux through K 2P /K 2P ‐like and K v /K v ‐like channels reduces extracellular K + levels, such reduction could consequently contribute to a decreased excitability of surrounding neurons. Open science badges: This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at https://cos.io/our-services/open-science-badges/ . image


  • Open Access

    A Molecular and Structural Mechanism for G Protein-mediated Microtubule Destabilization

    by Rahul H. Davé, Witchuda Saengsawang, Manu Lopus, Sonya Davé, Leslie Wilson, Mark M. Rasenick